Márk Plander

594 total citations
23 papers, 241 citations indexed

About

Márk Plander is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Márk Plander has authored 23 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Márk Plander's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Márk Plander is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Márk Plander collaborates with scholars based in Hungary and Germany. Márk Plander's co-authors include Gero Brockhoff, J Ivánýi, Ferdinand Hofstaedter, Gerd Schmitz, Péter Ugocsai, Ferdinand Hofstädter, E. Orsó, Ruth Knüchel, Stephan Schwarz and Simone Diermeier‐Daucher and has published in prestigious journals such as The Journal of Pathology, Leukemia and Cell Proliferation.

In The Last Decade

Márk Plander

20 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Márk Plander Hungary 8 101 87 82 66 56 23 241
Bérengère Vire United States 8 105 1.0× 94 1.1× 68 0.8× 103 1.6× 77 1.4× 19 268
Sandeep Potluri United Kingdom 8 144 1.4× 93 1.1× 95 1.2× 98 1.5× 102 1.8× 12 312
Giulia Poretti Italy 6 113 1.1× 106 1.2× 100 1.2× 59 0.9× 17 0.3× 12 283
F Davi France 6 118 1.2× 60 0.7× 68 0.8× 93 1.4× 29 0.5× 8 262
Rainer Boxhammer Germany 11 47 0.5× 77 0.9× 155 1.9× 82 1.2× 85 1.5× 26 322
Noelia Purroy Spain 10 159 1.6× 113 1.3× 88 1.1× 123 1.9× 18 0.3× 18 334
Margot Jak Netherlands 8 209 2.1× 89 1.0× 149 1.8× 199 3.0× 47 0.8× 23 394
G. García-Manero United States 8 162 1.6× 111 1.3× 64 0.8× 104 1.6× 23 0.4× 24 329
Gandhi Damaj France 8 78 0.8× 70 0.8× 81 1.0× 177 2.7× 15 0.3× 16 288
Lucia Savino Italy 8 185 1.8× 53 0.6× 54 0.7× 166 2.5× 23 0.4× 9 306

Countries citing papers authored by Márk Plander

Since Specialization
Citations

This map shows the geographic impact of Márk Plander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Márk Plander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Márk Plander more than expected).

Fields of papers citing papers by Márk Plander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Márk Plander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Márk Plander. The network helps show where Márk Plander may publish in the future.

Co-authorship network of co-authors of Márk Plander

This figure shows the co-authorship network connecting the top 25 collaborators of Márk Plander. A scholar is included among the top collaborators of Márk Plander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Márk Plander. Márk Plander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinczés, László Imre, Botond Tímár, Márk Plander, et al.. (2025). Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy. The Journal of Pathology. 266(4-5). 395–404.
2.
Plander, Márk, et al.. (2024). Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes. Pathology & Oncology Research. 30. 1611811–1611811. 1 indexed citations
3.
Varga, Gergely, et al.. (2022). Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary. Pathology & Oncology Research. 28. 1610645–1610645. 2 indexed citations
4.
5.
Mikala, Gábor, András Masszi, Péter Farkas, et al.. (2022). Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry. Pathology & Oncology Research. 28. 1610659–1610659. 5 indexed citations
6.
Plander, Márk, et al.. (2021). Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia. Hematological Oncology. 39(4). 513–520. 4 indexed citations
7.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
8.
Plander, Márk, et al.. (2018). In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment. Annals of Hematology. 97(11). 2145–2152. 9 indexed citations
9.
Kajtár, Béla, Judit Demeter, Miklós Egyed, et al.. (2017). A TP53-mutáció-analízis jelentősége krónikus lymphocytás leukaemiában | TP53mutation analysis in chronic lymphocytic leukaemia. 4 indexed citations
10.
Plander, Márk & Bernadette Kálmán. (2016). Rare autoimmune disorders with Mendelian inheritance. Autoimmunity. 49(5). 285–297. 5 indexed citations
11.
Ivánýi, J, et al.. (2016). Essentialis thrombocythaemiás betegek kezelési eredményei osztályunkon. Orvosi Hetilap. 157(9). 336–341. 1 indexed citations
12.
13.
Ivánýi, J, Éva Márton, & Márk Plander. (2012). Treatment outcome of immune thrombocytopenia. Orvosi Hetilap. 153(41). 1613–1621. 1 indexed citations
14.
Plander, Márk, Péter Ugocsai, Evelyn Orsó, et al.. (2011). Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma. Annals of Hematology. 90(12). 1381–1390. 22 indexed citations
15.
Ivánýi, J, Éva Márton, & Márk Plander. (2011). Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia. Orvosi Hetilap. 152(45). 1795–1803. 7 indexed citations
16.
Plander, Márk, Péter Ugocsai, Simone Diermeier‐Daucher, et al.. (2009). Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia. 23(11). 2118–2128. 55 indexed citations
17.
Ivánýi, J, et al.. (2009). Therapeutic management of central nervous system lymphomas in a single hematological institute. Orvosi Hetilap. 150(42). 1937–1944.
18.
Plander, Márk, et al.. (2008). Cellular immune response in Dupuytren's disease. Biochemia Medica. 193–200. 2 indexed citations
19.
Brockhoff, Gero, et al.. (2007). Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK‐BR‐3 breast cancer cell proliferation. Cell Proliferation. 40(4). 488–507. 71 indexed citations
20.
Plander, Márk, Gero Brockhoff, Stefan Barlage, et al.. (2003). Optimization of three‐ and four‐color multiparameter DNA analysis in lymphoma specimens. Cytometry Part A. 54A(1). 66–74. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bérengère Vire Breakdown of academic impact, for papers by Sandeep Potluri Breakdown of academic impact, for papers by Giulia Poretti Breakdown of academic impact, for papers by F Davi Breakdown of academic impact, for papers by Rainer Boxhammer Breakdown of academic impact, for papers by Noelia Purroy Breakdown of academic impact, for papers by Margot Jak Breakdown of academic impact, for papers by G. García-Manero Breakdown of academic impact, for papers by Gandhi Damaj Breakdown of academic impact, for papers by Lucia Savino
Rankless by CCL
2026